The coexistence of narcolepsy and multiple sclerosis: A case report
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system, characterized by myelin degeneration. Aside from general symptoms such as visual impairment, muscle weakness, and sensory abnormalities, sleep disorders are sometimes experienced by MS patients. Here, we report a rare case of a 21-year-old young male patient presenting with both MS and narcolepsy. Moreover, we also reviewed the potential pathophysiological mechanisms that linked these two diseases, including the involvement of the immune system and neuronal damage. This case report emphasized the significance of further research into the relationship between MS and narcolepsy and provided a valuable theoretical basis that MS might be a key cause of narcolepsy. In addition, therapeutic strategies for MS, such as ofatumumab, might help alleviate narcolepsy.
- Trapp BD, Peterson J, Ransohoff RM, et al., 1998, Axonal transection in the lesions of multiple sclerosis. N Engl J Med, 338: 278–285. https://doi.org/10.1056/nejm199801293380502
- Barun B, 2013, Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis. Clin Neurol Neurosurg, 115 Suppl 1: S82–S85. https://doi.org/10.1016/j.clineuro.2013.09.028
- Golden EC, Lipford MC, 2018, Narcolepsy: Diagnosis and management. Cleve Clin J Med, 85: 959–969. https://doi.org/10.3949/ccjm.85a.17086
- Thompson AJ, Banwell BL, Barkhof F, et al., 2018, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol, 17: 162–173. https://doi.org/10.1016/s1474-4422(17)30470-2
- Zawilska JB, Woldan-Tambor A, Płocka A, et al., 2012, Narcolepsy: Etiology, clinical features, diagnosis and treatment. Postepy Hig Med Dosw, 66: 771–786. https://doi.org/10.5604/17322693.1015529
- Ohayon MM, Priest RG, Zulley J, et al., 2002, Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology, 58: 1826–1833. https://doi.org/10.1212/wnl.58.12.1826
- Nishino S, Kanbayashi T, 2005, Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev, 9: 269–310. https://doi.org/10.1016/j.smrv.2005.03.004
- de Lecea L, Kilduff TS, Peyron C, et al., 1998, The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A, 95: 322–327. https://doi.org/10.1073/pnas.95.1.322
- Kanbayashi T, Shimohata T, Nakashima I, et al., 2009, Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: New neurochemical and immunological implications. Arch Neurol, 66: 1563–1566. https://doi.org/10.1001/archneurol.2009.264
- Kallweit U, Bassetti CLA, Oberholzer M, et al., 2018, Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis: Six new cases and a literature review. J Neurol, 265: 2071–2078. https://doi.org/10.1007/s00415-018-8949-x
- Orthmann-Murphy JL, Calabresi PA, 2017, Therapeutic application of monoclonal antibodies in multiple sclerosis. Clin Pharmacol Ther, 101: 52–64. https://doi.org/10.1002/cpt.547
- Leonavicius R, Adomaitiene V, 2014, Features of sleep disturbances in multiple sclerosis patients. Psychiatr Danub, 26: 249–255.
- Scammell TE, Luo G, Borker P, et al., 2020, Treatment of narcolepsy with natalizumab. Sleep, 43: zsaa050. https://doi.org/10.1093/sleep/zsaa050